AD is pathologically characterized by the abnormal accumulation of amyloid beta (Aβ) and hyperphosphorylated tau proteins in the brain, which leads to subsequent neurodegeneration and progressive cognitive decline (Bloom, 2014). This evidence concerns the gene MAPT and Alzheimer disease.